Browsing by Author Zhang, Xiao-shuai
Showing results 1 to 4 of 4
Issue Date | Title | Author(s) |
2-Nov-2023 | 3rd-Generation Tyrosine Kinase-Inhibitors and Azacitidine Are Safe and Effective in Myeloid Blast-Phase Chronic Myeloid Leukaemia and Result in a High Proportion of Subjects in 2 nd Chronic Phase Able to Receive a Transplant | Bao, Mei; Wang, Xiang; Zhang, Xiao-shuai; Li, Zong-ru; Gale, Robert Peter; Huang, Xiao-jun; Jiang, Qian |
May-2022 | Co-variates associated with outcomes of tyrosine kinase-inhibitor therapy in persons with chronic myeloid leukaemia initially presenting in accelerated phase | Yang, Sen; Zhang, Xiao-shuai; Gale, Robert Peter; Huang, Xiao-jun; Jiang, Qian |
2-Nov-2023 | A Predictive Scoring System for Therapy Failure of Tyrosine-Kinase Inhibitors in Patients with Chronic-Phase Chronic Myeloid Leukemia | Zhang, Xiao-shuai; Liu, Bingcheng; Huang, Jian; Du, Xin; Zhang, Yanli; Xu, Na; Liu, Xiaoli; Li Weiming; Lin, Hai; Zhu, Huanling; Yang, Yunfan; Pan, Ling; Huang, Xiao-jun; Jiang, Qian |
Jun-2022 | Predictive scoring systems for molecular responses in persons with chronic phase chronic myeloid leukemia receiving initial imatinib therapy | Zhang, Xiao-shuai; Gale, Robert Peter; Li, Zi-yu; Zhang, Meng-yu; Huang, Xiao-jun; Jiang, Qian |